Journal
DRUG DESIGN DEVELOPMENT AND THERAPY
Volume 15, Issue -, Pages 5087-5097Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S338748
Keywords
diminished ovarian reserve; clomiphene citrate; medroxyprogesterone acetate; controlled ovarian stimulation; in vitro fertilization; luteinizing hormone surge
Categories
Funding
- National Natural Science Foundation of China [81901551]
Ask authors/readers for more resources
The present study compared the efficiency of progestin-primed ovarian stimulation (PPOS) with clomiphene citrate (CC) supplementation (PPOS+CC) and the standard PPOS protocol for women with diminished ovarian reserve (DOR) of different ages. Results showed that CC supplementation in PPOS protocols alleviated pituitary suppression and resulted in more high-quality embryos for young women with DOR. However, older women with DOR may face higher risks of premature LH surge and poor oocyte maturation rate with PPOS+CC.
Purpose: The present study was designed to compare the efficiency of the progestin-primed ovarian stimulation (PPOS) protocol with clomiphene citrate (CC) supplementation (PPOS+CC) and the standard PPOS protocol for women of different ages with diminished ovarian reserve (DOR). Patients and Methods: This retrospective cohort study included 364 DOR women who underwent controlled ovarian stimulation with PPOS+CC (n = 223) or standard PPOS (n = 141). They were divided into subgroups based on age: <= 35 years and >35 years. Differences in baseline characteristics, ovarian stimulation characteristics, endocrinological characteristics, and clinical outcome between the two groups were assessed. Statistical analyses were stratified by age. Results: In all women with DOR, PPOS+CC was associated with a lower percentage of women with profound pituitary suppression than standard PPOS (0.0% vs 18.6%, P < 0.001 and 1.3% vs 11.0%, P = 0.002). In young women with DOR, more high-quality cleavage stage embryos were harvested (1.96 vs 1.38, P = 0.018) and a lower dosage of gonadotropin per oocyte retrieved was required (558.37 vs 909.82, P = 0.036) in PPOS+CC. In older women with DOR, PPOS+CC led to an increase in the incidence of luteinizing hormone (LH) surge levels above 10 IU/L on trigger day (12.7% vs 4.9%, P = 0.028) and a decrease in the rate of oocyte maturation (84.7% vs 89.9%, P = 0.034) compared to standard PPOS. Conclusion: Clomiphene citrate is an effective adjuvant to alleviate pituitary suppression in PPOS protocols; for young women with DOR, CC supplementation had a positive impact on the number of high-quality embryos. However, older women with DOR would be at risk of developing a premature LH surge and having poor oocyte maturation rate under the PPOS+CC protocol.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available